Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does MONTELUKAST Cause Pulmonary embolism? 265 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 265 reports of Pulmonary embolism have been filed in association with MONTELUKAST (Montelukast). This represents 1.0% of all adverse event reports for MONTELUKAST.

265
Reports of Pulmonary embolism with MONTELUKAST
1.0%
of all MONTELUKAST reports
67
Deaths
176
Hospitalizations

How Dangerous Is Pulmonary embolism From MONTELUKAST?

Of the 265 reports, 67 (25.3%) resulted in death, 176 (66.4%) required hospitalization, and 96 (36.2%) were considered life-threatening.

Is Pulmonary embolism Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for MONTELUKAST. However, 265 reports have been filed with the FAERS database.

What Other Side Effects Does MONTELUKAST Cause?

Asthma (8,372) Dyspnoea (6,354) Wheezing (5,159) Drug ineffective (3,539) Cough (3,475) Therapeutic product effect incomplete (3,352) Anxiety (2,994) Loss of personal independence in daily activities (2,736) Sleep disorder due to a general medical condition (2,101) Obstructive airways disorder (2,073)

What Other Drugs Cause Pulmonary embolism?

RIVAROXABAN (3,282) LENALIDOMIDE (2,976) APIXABAN (2,714) ETHINYL ESTRADIOL\ETONOGESTREL (2,370) TESTOSTERONE (2,043) RITUXIMAB (1,764) ADALIMUMAB (1,663) PREDNISONE (1,586) METHOTREXATE (1,508) DEXAMETHASONE (1,336)

Which MONTELUKAST Alternatives Have Lower Pulmonary embolism Risk?

MONTELUKAST vs MONTELUKAST\MONTELUKAST MONTELUKAST vs MONTMORILLONITE MONTELUKAST vs MORNIFLUMATE MONTELUKAST vs MOROCTOCOG ALFA MONTELUKAST vs MORPHINE

Related Pages

MONTELUKAST Full Profile All Pulmonary embolism Reports All Drugs Causing Pulmonary embolism MONTELUKAST Demographics